Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links

Drugs

-

Sirolimus (marketed as Rapamune) Information

-

Healthcare Professional Information

Information for Healthcare Professionals: Immunosuppressant Drugs: Required Labeling Changes
FDA ALERT [07/14/2009]
Information for Healthcare Professionals: Sirolimus (marketed as Rapamune)
FDA ALERT [06/11/2009]

-

-

Other Information

Rapamune (sirolimus) Oral Solution and Tablets Label and Patient Information
Rapamune (sirolimus) Oral Solution and Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- January 2008

-

-

-